Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
Hong Kong student leaders arrested as police clear protest site
Thai junta chief says has not 'damaged' country, rights group disagrees
Mystery of Alexander the Great-era tomb holds Greeks in thrall
Buckwheat problem gives Putin food for thought
Flournoy withdraws from consideration as U.S. defence secretary - sources
Myanmar political leaders to hold talks on amending constitution
Scott out to bury Sydney hurt against inspirational McIlroy
Twitter in talks to buy Bieber backed selfie app Shots
Woman alleges road bully assaulted her 71-year-old father
Copyright © 1995-2014 Star Publications (M) Bhd (Co No 10894-D)